Navigation Links
Beetles drive groundbreaking conservation project
Date:5/19/2009

They are cursed the world over for contaminating food supplies and are a huge commercial pest, but the humble flour beetle is about to play a significant role in the management of endangered species.

The flour beetle or Tribolium castaneum will be the model in a major new study into the consequences of inbreeding, launched at the University of East Anglia (UEA) this summer.

Inbreeding is a potentially important problem in declining species across the world, and conserving genetic variation is now recognised as a priority by the International Union for Conservation of Nature.

When populations become isolated or depleted due to loss of habitat or exploitation, the gene pool is reduced which forces inbreeding between relatives, and therefore losses in genetic variability. This results in the increased expression of 'bad genes' which were previously hidden in a variable genome, leading to a range of problems usually associated with reproduction. This inbreeding depression then adds to the habitat loss or exploitation problems, further driving a population towards extinction.

Funded by the Natural Environment Research Council (NERC), the 400,000 project will experimentally evaluate which specific reproductive traits are affected by inbreeding, and how they impact on population viability. Once inbreeding depression and its causes are discovered, the project will determine how much new variability must be re-introduced to genetically rescue an inbred population from extinction.

The results of the three-year study will help managers of conservation and captive breeding projects recognise when inbreeding is a problem, how it progresses, and how best to manage or reverse it.

"When a species is under threat, it is difficult to be sure whether inbreeding or other stresses are responsible for declines in numbers," said Dr Matthew Gage of UEA's School of Biological Sciences.

"Our previous work on wild r
'/>"/>

Contact: Simon Dunford
s.dunford@uea.ac.uk
44-160-359-2203
University of East Anglia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Virus Could Help Drive Obesity
2. Back to School Means Return of School Blood Drives
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. End-to-End HR Performance Benchmarks: Metrics That Will Help Turn the HR Cost Center into a Productivity Driver
5. Customized virus kills brain tumor stem cells that drive lethal cancer
6. National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline
7. Cancer stem cell subpopulation drives metastasis of human pancreatic cancer
8. Brain Defect Helps Drive Fragile X Syndrome
9. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
10. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
11. Disabilities Rising Among Workers; Need for Employer-Driven Disability Awareness, Support Efforts Also Increases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... , NEW ORLEANS, Dec. 5 Leukemia and myelopr... blood cancers. Research presented today at the 51...ology introduces potential new treatment options a...ing from acute promyelocytic leukemia, chronic mye..., and myelofibrosis that are based on a better und...
(Date:12/5/2009)... The MAMA campaign is a col...ertified Professional Midwives (NACPM), Midwives A...ifery (CfM), International Center for Traditional ...dwives (NARM), and the Midwifery Education Accredi...efforts of The MAMA Campaign to secure federal rec...
(Date:12/4/2009)... , SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won...sary in the SF Bay Area by popular vote conducted ... only three months in operation, the SF Bay commun...tion for accessing medicinal marijuana. ,, The r...e obvious: a dispensary which caters to the consum...
(Date:12/4/2009)... , MADISON HEIGHTS, Mich., Dec. 4 The E...of BetterInvesting Magazine today announced All...Stock to Study" and C.R. Bard, Inc. (NYSE: BCR...vestors, informational and educational use. ,, "Th...tunities involving its flagship drug Botox and oth...
(Date:12/4/2009)... , STANFORD, Calif. A new study shows that muscl...s ability to squeeze shut properly. The work, perf...t patients with conditions such as gastric reflux ...sed to strengthen sphincters, which are the bands ... intestinal tract. Weakness in these areas can cau...
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4
...ould use,a little pampering now and then. Think yo... survivorship? Let the Pennsylvania Breast Cancer ...e of everything!, All you have to do is tell us i... for a real treat! Salon Art,Tiff, located on the ...
...lps Answer That Question, BREA, Calif., March 5 ...health insurance Web site in the United States, no...r intellectually challenged,their dogs are with a ... dog,s brain power. VPI,s Canine Aptitude Test,is ...
... expert says , , WEDNESDAY, March 5 (Healt... a person,s sensitivity to warfarin are important ...ing drug, researchers report. , That information a...tic test when first prescribing warfarin, better k...
...ccess to necessary medications for ...rch 5 Today Eli Lilly and,Company (NYSE: LLY ) r...ity,-- the principle that insurers should treat me...eks to pay for the bill:,by increasing the so-call...
... leading global,provider of clinical documentation...for the release of its financial results for the f...lans to issue its earnings release for the fourth ....m. CT.,The number to call for this interactive te...
...d revenues of $82.9 million, up 18% from the prior...er, - Earnings per share of $0.26, an increase of ... year,s first quarter - Operati...fe,sDHA(TM), COLUMBIA, Md., March 5 Martek Biosc...
Other Medicine News:Health News:The Pennsylvania Breast Cancer Coalition Announces Last Chance to Enter 'Makeover for Mom' Contest 2Health News:Is Your Dog a Canine-stein or a Bonehead? 2Health News:Is Your Dog a Canine-stein or a Bonehead? 3Health News:Genetic Test Predicts Response to Warfarin 2Health News:Genetic Test Predicts Response to Warfarin 3Health News:Mental Health Parity Laudable, But House Legislation Would Put Medicaid Patients at Risk, Lilly Says 2Health News:Mental Health Parity Laudable, But House Legislation Would Put Medicaid Patients at Risk, Lilly Says 3Health News:Martek Announces First Quarter 2008 Financial Results 2Health News:Martek Announces First Quarter 2008 Financial Results 3Health News:Martek Announces First Quarter 2008 Financial Results 4Health News:Martek Announces First Quarter 2008 Financial Results 5Health News:Martek Announces First Quarter 2008 Financial Results 6Health News:Martek Announces First Quarter 2008 Financial Results 7Health News:Martek Announces First Quarter 2008 Financial Results 8Health News:Martek Announces First Quarter 2008 Financial Results 9Health News:Martek Announces First Quarter 2008 Financial Results 10Health News:Martek Announces First Quarter 2008 Financial Results 11
(Date:12/3/2009)...WARRENDALE, Pa., Dec. 3 Radiology imaging leader ...ntegration capabilities at the November 2009 Radio...nnect.PACS(TM) product, enabling the first radiol...atest release in the company,s newly branded Cert...p://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
(Date:12/3/2009)... HOERSHOLM, Denmark and SAN DIEGO, California, D...iR-122, a microRNA Important for,Hepatitis C Viral...itis C,Virus in the Bloodstream in Chimpanzees Chr... - SPC3649 Demonstrates Efficacy With No Evidence ...in the Treated Animals - Signaling a Potential,Ben...
(Date:12/3/2009)....C., Dec. 3 In response to the increasingly criti... the evolving healthcare delivery system, Duke Med...matics (DCHI) to provide a campus focus for health...rdisciplinary approach to education that will prod...lthcare administrators with an expertise in the us...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Drop in Certain Visual Skills May Precede Alzheimers 59310 1Drop in Certain Visual Skills May Precede Alzheimers 59310 2With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 1With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 2With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 3Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 1Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 2Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 3Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 4
...15 Pre-mixed insulin,analogues, a modified form o...ffective than long-acting analogues for controllin...with type 2 diabetes, according to a report,funded..., part of the U.S.,Department of Health and Human ...however, appears to be equally,effective as pre-mi...
.... 15 , -- Results inconclusive, as primary outcom...ther donepezil or AZD3480; results impacted by ...own on secondary outcome measures ADCS-CGIC and MM...mparable to placebo, with fewer GI-related AEs...alysis of full dataset and planned discussions...
Other Medicine Technology:Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 2Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 2AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 4
Teardrop punch, Left
Meniscus Screw
Biosteon™ (HA/PLLA) Wedge Interference Screws
Graft Workstation
Medicine Products: